Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies.

Christidis, Daniel; McGrath, Shannon; Perera, Marlon; Manning, Todd; Bolton, Damien; Lawrentschuk, Nathan

Christidis, Daniel; McGrath, Shannon; Perera, Marlon; Manning, Todd; Bolton, Damien; Lawrentschuk, Nathan.

Afiliação

Christidis D; Department of Surgery, University of Melbourne, Austin Health, Melbourne, Australia.
McGrath S; Young Urology Researchers Organization (YURO), Melbourne, Australia.
Perera M; Department of Surgery, University of Melbourne, Austin Health, Melbourne, Australia.
Manning T; Young Urology Researchers Organization (YURO), Melbourne, Australia.
Bolton D; Department of Surgery, University of Melbourne, Austin Health, Melbourne, Australia.
Lawrentschuk N; Young Urology Researchers Organization (YURO), Melbourne, Australia.

Prostate Int ; 5(2): 41-46, 2017 Jun.

Article em En | MEDLINE | ID: mdl-28593165

Palavras-chave

Aquablation; Benign prostatic hypertrophyprostatic artery embolization; Minimally invasive surgical therapies; Prostatic stenting

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Revista: Prostate Int Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google